Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug.
| Image |  |
|---|---|
| Description | scientific article published in April 2013 |
| Author/s | |
| Publication date | April 1, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |